Bayer and Vanderbilt University Medical Center to advance treatments for cardiovascular and kidney diseases

The collaboration will leverage VUMC’s resource platform, including its comprehensive datasets hosted in Vanderbilt’s BioVU collection of DNA and plasma to enable data-driven insights and to accelerate discovery and development.